Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Cygnus Bioscience Raises $14 Million for Gene Sequencing Machines

publication date: Jun 15, 2020

Cygnus Biosciences, a Beijing company developing next-gen gene sequencing machines, completed a C round of at least $14 million. The funding was led by Guangzhou High-tech Zone Science and Technology Holdings, and Cygnus will build an industrial base, an R&D center and its sales headquarters in the Guangzhou park. Cygnus has developed a high-precision sequencing technology that applies an error-correcting decoding algorithm after the sequencing to improve accuracy. The company's goal is to provide high-end sequencing machines at a lower price. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here